| [1] |
Chinese Society of Endocrinology. Guidelines on the diagnosis and treatment of thyroid diseases——Hyperthyroidism[J]. Chin J Intern Med, 2007, 46(10): 876-882. DOI: 10.3760/j.issn: 0578-1426.2007.10.035.
|
| [2] |
WAFA B, FATEN H, MOUNA E, et al. Hyperthyroidism and hepatic dysfunction: Report of 17 cases[J]. JGH Open, 2020, 4(5): 876-879. DOI: 10.1002/jgh3.12337. |
| [3] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007 |
| [4] |
Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol, 2015, 31(11): 1752-1768. DOI: 10.3969/j.issn.1001-5256.2015.11.002. |
| [5] |
REN YT, WANG JJ. Clinical analysis of 176 cases of liver function damage in hyperthyroidism[J]. Public Med Forum Magaz, 2012, 16(5): 583-585. DOI: 10.3969/j.issn. 1672-1721.2012.05.030.
任艳婷, 王娟娟. 甲状腺功能亢进症患者肝功能损害176例临床分析[J]. 基层医学论坛, 2012, 16(5): 583-585. DOI: 10.3969/j.issn. 1672-1721.2012.05.030.
|
| [6] |
ZHANG R, TIAN X, QIN L, et al. Factors predicting abnormal liver function tests induced by Graves' disease alone: A retrospective cohort study[J]. Medicine (Baltimore), 2015, 94(19): e839. DOI: 10.1097/MD.0000000000000839. |
| [7] |
SHIMIZU Y. Liver in systemic disease[J]. World J Gastroenterol, 2008, 14(26): 4111-4119. DOI: 10.3748/wjg.14.4111. |
| [8] |
MYERS JD, BRANNON ES, HOLLAND BC. A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism[J]. J Clin Invest, 1950, 29(8): 1069-1077. DOI: 10.1172/JCI102338. |
| [9] |
de CAMPOS MAZO DF, de VASCONCELOS GB, PEREIRA MA, et al. Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism[J]. Clin Exp Gastroenterol, 2013, 6: 9-17. DOI: 10.2147/CEG.S39358. |
| [10] |
YANG J, ZHONG J, ZHOU LZ, et al. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole[J]. Intern Med, 2012, 51(16): 2189-2192. DOI: 10.2169/internalmedicine. 51.7845.
|
| [11] |
HEIDARI R, NIKNAHAD H, JAMSHIDZADEH A, et al. Factors affecting drug-induced liver injury: antithyroid drugs as instances[J]. Clin Mol Hepatol, 2014, 20(3): 237-248. DOI: 10.3350/cmh.2014.20.3.237. |
| [12] |
YANG J, LI LF, XU Q, et al. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China[J]. Thyroid, 2015, 25(3): 278-283. DOI: 10.1089/ thy.2014.0350.
|
| [13] |
HE K, HU Y, XU XH, et al. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease[J]. Exp Clin Endocrinol Diabetes, 2014, 122(6): 368-372. DOI: 10.1055/s-0034-1375667. |
| [14] |
ZHANG W, WANG X, LI P, et al. Evaluating hyperthyroidism-induced liver injury based on in situ fluorescence imaging of glutathione and phosphate via nano-MOFs sensor[J]. Anal Chem, 2020, 92(13): 8952-8958. DOI: 10.1021/acs.analchem.0c00925. |
| [15] |
LI C, TAN J, ZHANG G, et al. Risk factors of hyperthyroidism with hepatic function injury: A 4-year retrospective study[J]. Horm Metab Res, 2015, 47(3): 209-213. DOI: 10.1055/s-0034-1375690. |
| [16] |
WANG R, TAN J, ZHANG G, et al. Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment[J]. Medicine (Baltimore), 2017, 96(5): e6035. DOI: 10.1097/MD.0000000000006035. |
| [17] |
|
| [18] |
WANG MT, LEE WJ, HUANG TY, et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: A population-based cohort study[J]. Br J Clin Pharmacol, 2014, 78(3): 619-629. DOI: 10.1111/bcp.12336. |
| [19] |
NICULESCU DA, DUSCEAC R, GALOIU SA, et al. Serial changes of liver function tests before and during methimazole treatment in thyrotoxic patients[J]. Endocr Pract, 2016, 22(8): 974-979. DOI: 10.4158/EP161222.OR. |
| [20] |
CHANG LC, CHANG CC, CHEN PL, et al. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions[J]. Expert Opin Drug Saf, 2018, 17(8): 775-784. DOI: 10.1080/14740338.2018.1502747. |
| [21] |
GURGUL E, SOWINSKI J. Primary hyperthyroidism-diagnosis and treatment. Indications and contraindications for radioiodine therapy[J]. Nucl Med Rev Cent East Eur, 2011, 14(1): 29-32.
|
| [22] |
DING Y, XING J, QIU Z, et al. Radioactive iodine therapy without recent antithyroid drug pretreatment for hyperthyroidism complicated by severe hyperbilirubinemia due to hepatic dysfunction: Experience of a chinese medical center[J]. Endocr Pract, 2016, 22(2): 173-179. DOI: 10.4158/EP15736.OR. |
| [23] |
KLANGJAREONCHAI T. An unusual case of hyperthyroidism associated with jaundice and hypercalcaemia[J]. BMJ Case Rep, 2012, 2012: bcr1120115076. DOI: 10.1136/bcr.11.2011.5076. |
| [24] |
HULL K, HORENSTEIN R, NAGLIERI R, et al. Two cases of thyroid storm-associated cholestatic jaundice[J]. Endocr Pract, 2007, 13(5): 476-480. DOI: 10.4158/EP.13.5.476. |
| [25] |
ARAB DM, MALATJALIAN DA, RITTMASTER RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole[J]. J Clin Endocrinol Metab, 1995, 80(4): 1083-1085. DOI: 10.1210/jcem.80.4.7714072. |
DownLoad: